Ceramides and Ceramide Scores: Clinical Applications for Cardiometabolic Risk Stratification
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ceramides and Ceramide Scores: Clinical Applications for Cardiometabolic Risk Stratification
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-09-29
DOI
10.3389/fendo.2020.570628
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Influence of Exercise Training on Skeletal Muscle Insulin Resistance in Aging: Spotlight on Muscle Ceramides
- (2020) Paul T. Reidy et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The role of ceramides in metabolic disorders: when size and localization matters
- (2020) Sarah M. Turpin-Nolan et al. Nature Reviews Endocrinology
- Plasma levels of ceramides relate to ischemic stroke risk and clinical severity
- (2020) Yong-kun Gui et al. BRAIN RESEARCH BULLETIN
- Lipid Accumulation in Hearts Transplanted From Nondiabetic Donors to Diabetic Recipients
- (2020) Raffaele Marfella et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Ceramide Biomarkers Predictive of Cardiovascular Disease Risk Increase in Healthy Older Adults After Bed Rest
- (2020) Jonathan J Petrocelli et al. JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
- Plasma Ceramides in Relation to Coronary Plaque Characterization Determined by Optical Coherence Tomography
- (2020) Weili Pan et al. Journal of Cardiovascular Translational Research
- Prediction of Residual Risk by Ceramide‐Phospholipid Score in Patients With Stable Coronary Heart Disease on Optimal Medical Therapy
- (2020) Mika Hilvo et al. Journal of the American Heart Association
- Ceramides and diabetes mellitus: an update on the potential molecular relationships
- (2019) H. Yaribeygi et al. DIABETIC MEDICINE
- Plasma Ceramides and Sphingomyelins in Relation to Heart Failure Risk
- (2019) Rozenn N. Lemaitre et al. Circulation-Heart Failure
- Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients
- (2019) Mika Hilvo et al. EUROPEAN HEART JOURNAL
- Targeting a ceramide double bond improves insulin resistance and hepatic steatosis
- (2019) Bhagirath Chaurasia et al. SCIENCE
- 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
- (2019) François Mach et al. EUROPEAN HEART JOURNAL
- 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
- (2019) Juhani Knuuti et al. EUROPEAN HEART JOURNAL
- Biomarkers and Clinical Cardiovascular Outcomes With Ezetimibe in the IMPROVE-IT Trial
- (2019) Arman Qamar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Role of Ceramides in Insulin Resistance
- (2019) Emilia Sokolowska et al. Frontiers in Endocrinology
- Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease
- (2019) Annelise M. Poss et al. JOURNAL OF CLINICAL INVESTIGATION
- Ceramides and sphingosine-1-phosphate as potential markers in diagnosis of ischaemic stroke
- (2019) Anna Fiedorowicz et al. Neurologia i Neurochirurgia Polska
- PCSK9 inhibition alters the lipidome of plasma and lipoprotein fractions
- (2018) Mika Hilvo et al. ATHEROSCLEROSIS
- Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: An Analysis from FOURIER
- (2018) Marc S. Sabatine et al. CIRCULATION
- Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family Study
- (2018) Rozenn N. Lemaitre et al. DIABETES
- Fenofibrate decreases plasma ceramide in type 2 diabetes patients: A novel marker of CVD?
- (2018) M. Croyal et al. DIABETES & METABOLISM
- Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars
- (2018) Panu K. Luukkonen et al. DIABETES CARE
- Ceramide stearic to palmitic acid ratio predicts incident diabetes
- (2018) Mika Hilvo et al. DIABETOLOGIA
- Plasma concentrations of molecular lipid species predict long-term clinical outcome in coronary artery disease patients
- (2018) Sharda S. Anroedh et al. JOURNAL OF LIPID RESEARCH
- The effect of high fat diet and metformin treatment on liver lipids accumulation and their impact on insulin action
- (2018) Piotr Zabielski et al. Scientific Reports
- Ceramide Remodeling and Risk of Cardiovascular Events and Mortality
- (2018) Linda R. Peterson et al. Journal of the American Heart Association
- Relation of plasma ceramides to visceral adiposity, insulin resistance and the development of type 2 diabetes mellitus: the Dallas Heart Study
- (2018) Ian J. Neeland et al. DIABETOLOGIA
- What’s new in the Fourth Universal Definition of Myocardial infarction?
- (2018) Kristian Thygesen EUROPEAN HEART JOURNAL
- SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
- (2018) Thomas A Zelniker et al. LANCET
- Effect of metformin on bioactive lipid metabolism in insulin-resistant muscle
- (2017) Piotr Zabielski et al. JOURNAL OF ENDOCRINOLOGY
- Coronary Artery Calcium Scoring
- (2017) Michael J. Blaha et al. JACC-Cardiovascular Imaging
- Plasma Dihydroceramides Are Diabetes Susceptibility Biomarker Candidates in Mice and Humans
- (2017) Leonore Wigger et al. Cell Reports
- Circulating Ceramides Predict Cardiovascular Outcomes in the Population-Based FINRISK 2002 CohortHighlights
- (2016) Aki S. Havulinna et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol
- (2016) Reijo Laaksonen et al. EUROPEAN HEART JOURNAL
- Plasma Ceramides Independently Predict Coronary Artery Disease and Major Adverse Cardiovascular Events*
- (2016) Jeffrey Meeusen et al. Journal of Clinical Lipidology
- Control of inflammatory responses by ceramide, sphingosine 1-phosphate and ceramide 1-phosphate
- (2016) Antonio Gomez-Muñoz et al. PROGRESS IN LIPID RESEARCH
- Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
- (2016) Allan D. Sniderman et al. Journal of the American Heart Association
- Effect of pioglitazone on plasma ceramides in adults with metabolic syndrome
- (2015) Jeremy T. Warshauer et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Improved insulin sensitivity after exercise training is linked to reduced plasma C14:0 ceramide in obesity and type 2 diabetes
- (2015) Takhar Kasumov et al. Obesity
- Ceramides – Lipotoxic Inducers of Metabolic Disorders
- (2015) Bhagirath Chaurasia et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Dose-Dependent Effects of Rosuvastatin on the Plasma Sphingolipidome and Phospholipidome in the Metabolic Syndrome
- (2014) Theodore W. K. Ng et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Ceramide: A simple sphingolipid with unique biophysical properties
- (2014) Bruno M. Castro et al. PROGRESS IN LIPID RESEARCH
- Molecular Lipids Identify Cardiovascular Risk and Are Efficiently Lowered by Simvastatin andPCSK9Deficiency
- (2013) Kirill Tarasov et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Role of ceramide in diabetes mellitus: evidence and mechanisms
- (2013) Sehamuddin Galadari et al. Lipids in Health and Disease
- Ceramide and Apoptosis: Exploring the Enigmatic Connections between Sphingolipid Metabolism and Programmed Cell Death
- (2012) Thomas D. Mullen et al. Anti-Cancer Agents in Medicinal Chemistry
- Plasma Lipidomic Analysis of Stable and Unstable Coronary Artery Disease
- (2011) Peter J. Meikle et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Serine palmitoyltransferase inhibitor myriocin induces the regression of atherosclerotic plaques in hyperlipidemic ApoE-deficient mice
- (2008) T PARK et al. PHARMACOLOGICAL RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started